Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PAHC
PHIBRO ANIMAL HEALTH CORPORATION
NASDAQ
$37.67
▲ UP 3.63% (1.32)

KEY STATISTICS

Market Cap$1.53 B
52w High$60.08
52w Low$28.25
Dividend Yield1.32%
FrequencyQuarterly
P/E12.86
Volume362.75K
Shares Out.40.54M

COMPANY

LEADERSHIP

Daniel Bendheim
CHIEF EXECUTIVE
Daniel Bendheim

COMPENSATION 2026

Salary$2,442,600
Stock Awards$0
Incentive Plan Pay$1,677,300
All Other Comp.$496,135
Total$5,284,122

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 11, 2014
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2,605

PRICE TARGET

Target High$49.00
Target Low$17.00
Target Median$18.00
Target Consensus$28.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$379.38M
NOV
4
WED

PRICE

$37.67 ▲ UP 3.63% (+$1.32)
$36.75$37.50$38.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM37.67

About Phibro Animal Health Corporation

https://www.pahc.com ↗

Phibro Animal Health develops and supplies animal health, mineral nutrition, and performance products for livestock worldwide, including vaccines, antibacterials, anticoccidials, and nutritional supplements for poultry, swine, cattle, and aquacult...

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT PHIBRO ANIMAL HEALTH CORPORATION IS KNOWN FOR

Medicated Feed Additive (MFA) Portfolio
Medicated Feed Additive (MFA) Portfolio

After acquiring Zoetis' portfolio in late 2024, Phibro's leading offerings include over 37 medicated feed additive products for livestock, enhancing animal health and productivity in poultry, swine, and cattle.

COMPETITORS

COMPETITOR
ELAN COMPARE
IDXX COMPARE
MRK COMPARE
NEOG COMPARE
ZTS COMPARE

Revenue by Products

IconPRODUCTQ1-2026Q2-2026Q3-2026Q4-2026
Vaccines$40.11M $37.64M ▼$38.63M ▲$40.05M ▲

Revenue by Geography

MapREGIONQ1-2026Q2-2026Q3-2026Q4-2026
UNITED STATES$202.35M $221.76M ▲$232.77M ▲$220.25M ▼
Latin America and Canada$87.23M $87.6M ▲$75.62M ▼$90.22M ▲
EMEA$44.94M $44.78M ▼$44.47M ▼$53.75M ▲
Asia Pacific$29.38M $19.77M ▼$30.68M ▲$32.52M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
173
LISTED HERE
26
RANKED BY POSITION SIZE
XUU.TO
0.00% · 1.3M
VTS.AX
0.00% · 659.6K
XPH
1.38% · 223.5K
XSMO
0.24% · 202.9K
SCHA
0.02% · 101.5K
FDM
1.26% · 92.5K
FESM
0.05% · 91.4K
DFMC
0.03% · 74.0K
DES
0.11% · 65.9K
JMEE
0.07% · 57.4K
PSC
0.07% · 51.5K
SMIZ
0.52% · 38.0K
GSSC
0.09% · 26.8K
AVSC
0.03% · 23.8K
NUSC
0.06% · 21.4K
HAPS
0.42% · 20.4K
XRSU.L
0.02% · 19.2K
AI
AIMS
0.60% · 14.2K
BFOR
0.16% · 10.4K
RSSL
0.02% · 10.0K
TPSC
0.09% · 9.3K
ROSC
0.60% · 8.9K
WSCSRI.SW
0.03% · 6.3K
SYZ
0.34% · 6.3K
PILL
0.93% · 6.3K
EB
EBI
0.03% · 5.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
46.33%
HOLDERS
364
TOP 12 OF 364 · RANKED BY POSITION SIZE
Blackrock Inc.
3.5M sh · $58.77M
Blackrock, Inc.
3.4M sh · $138.62M
Fmr LLC
3.2M sh · $99.23M
Blackrock Fund Advisors
1.7M sh · $50.14M
Vanguard Group Inc
1.5M sh · $57.52M
State Street Corp
1.0M sh · $32.61M
Millennium Management LLC
936.7K sh · $29.41M
Acadian Asset Management LLC
785.8K sh · $31.78M
Blackrock Advisors LLC
717.6K sh · $21.02M
Geode Capital Management, LLC
657.4K sh · $20.64M
Lord, Abbett & Co. LLC
653.3K sh · $20.51M
Amundi Asset Management Us, Inc.
650.7K sh · $15.94M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Michael McCaul
Michael McCaul
Sale
2022-09-01

INSIDER TRADES

★
OFFICER: VP FINANCE AND TREASURER
Rodriguez Patrick
Purchase · 1.5K shares
2026-08-06
★
OFFICER: CHIEF FINANCIAL OFFICER
David Glenn
Purchase · 3.3K shares
2026-08-06
★
OFFICER: CHIEF OPERATING OFFICER
Miller Larry Lee
Purchase · 3.5K shares
2026-08-06
★
DIRECTOR
BENDHEIM Jonathan
Purchase · 2.7K shares
2026-08-06

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 1
OVERWEIGHT 1
2 GRADES IN THE LAST 12 MONTHS
Citigroup NEUTRAL JP Morgan OVERWEIGHT

SECTORS PEERS

PEERPRICE
OGN$13.76COMPARE
MD$26.61COMPARE
AUPH$16.29COMPARE
ALVO$4.95COMPARE
ANIP$72.83COMPARE
MNKD$3.95COMPARE
EVO$1.91COMPARE
TLRY$4.59COMPARE